The association between varying levels of palliative care involvement on costs during terminal hospitalizations in Canada from 2012 to 2015.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
13 Apr 2021
Historique:
received: 26 07 2020
accepted: 30 03 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 15 5 2021
Statut: epublish

Résumé

Inpatient palliative care is associated with lower inpatient costs; however, this has yet to be studied using a more nuanced, multi-tiered measure of inpatient palliative care and a national population-representative dataset. Using a population-based cohort of Canadians who died in hospital, our objectives were to: describe patients' receipt of palliative care and active interventions in their terminal hospitalization; and examine the relationship between inpatient palliative care and hospitalization costs. Retrospective cohort study using data from the Discharge Abstract Database in Canada between fiscal years 2012 and 2015. The cohort were Canadian adults (age ≥ 18 years) who died in hospital between April 1st, 2012 and March 31st, 2015 (N = 250,640). The exposure was level of palliative care involvement defined as: medium-high, low, or no palliative care. The main measure was acute care costs calculated using resource intensity weights multiplied by the cost of standard hospital stay, represented in 2014 Canadian dollars (CAD). Descriptive statistics were represented as median (IQR), and n(%). We modelled cost as a function of palliative care using a gamma generalized estimating equation (GEE) model, accounting for clustering by hospital. There were 250,640 adults who died in hospital. Mean age was 76 (SD 14), 47% were female. The most common comorbidities were: metastatic cancer (21%), heart failure (21%), and chronic obstructive pulmonary disease (16%). Of the decedents, 95,450 (38%) had no palliative care involvement, 98,849 (38%) received low involvement, and 60,341 (24%) received medium to high involvement. Controlling for age, sex, province and predicted hospital mortality risk at admission, the cost per day of a terminal hospitalization was: $1359 (95% CI 1323: 1397) (no involvement), $1175 (95% CI 1146: 1206) (low involvement), and $744 (95% CI 728: 760) (medium-high involvement). Increased involvement of palliative care was associated with lower costs. Future research should explore whether this relationship holds for non-terminal hospitalizations, and whether palliative care in other settings impacts inpatient costs.

Sections du résumé

BACKGROUND BACKGROUND
Inpatient palliative care is associated with lower inpatient costs; however, this has yet to be studied using a more nuanced, multi-tiered measure of inpatient palliative care and a national population-representative dataset. Using a population-based cohort of Canadians who died in hospital, our objectives were to: describe patients' receipt of palliative care and active interventions in their terminal hospitalization; and examine the relationship between inpatient palliative care and hospitalization costs.
METHODS METHODS
Retrospective cohort study using data from the Discharge Abstract Database in Canada between fiscal years 2012 and 2015. The cohort were Canadian adults (age ≥ 18 years) who died in hospital between April 1st, 2012 and March 31st, 2015 (N = 250,640). The exposure was level of palliative care involvement defined as: medium-high, low, or no palliative care. The main measure was acute care costs calculated using resource intensity weights multiplied by the cost of standard hospital stay, represented in 2014 Canadian dollars (CAD). Descriptive statistics were represented as median (IQR), and n(%). We modelled cost as a function of palliative care using a gamma generalized estimating equation (GEE) model, accounting for clustering by hospital.
RESULTS RESULTS
There were 250,640 adults who died in hospital. Mean age was 76 (SD 14), 47% were female. The most common comorbidities were: metastatic cancer (21%), heart failure (21%), and chronic obstructive pulmonary disease (16%). Of the decedents, 95,450 (38%) had no palliative care involvement, 98,849 (38%) received low involvement, and 60,341 (24%) received medium to high involvement. Controlling for age, sex, province and predicted hospital mortality risk at admission, the cost per day of a terminal hospitalization was: $1359 (95% CI 1323: 1397) (no involvement), $1175 (95% CI 1146: 1206) (low involvement), and $744 (95% CI 728: 760) (medium-high involvement).
CONCLUSIONS CONCLUSIONS
Increased involvement of palliative care was associated with lower costs. Future research should explore whether this relationship holds for non-terminal hospitalizations, and whether palliative care in other settings impacts inpatient costs.

Identifiants

pubmed: 33849539
doi: 10.1186/s12913-021-06335-1
pii: 10.1186/s12913-021-06335-1
pmc: PMC8045222
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331

Subventions

Organisme : CIHR
ID : CIHR SDA-156943
Pays : Canada
Organisme : Health Research Board in Ireland
ID : ARPP-A-2018-005

Références

BMC Palliat Care. 2018 Apr 5;17(1):58
pubmed: 29622004
JAMA Intern Med. 2018 Jun 1;178(6):820-829
pubmed: 29710177
J Palliat Med. 2010 Nov;13(11):1365-9
pubmed: 21039226
J Palliat Med. 2016 Apr;19(4):421-7
pubmed: 26871522
Health Serv Res. 2015 Feb;50(1):217-36
pubmed: 25040226
Ann Palliat Med. 2015 Jul;4(3):99-121
pubmed: 26231807
Support Care Cancer. 2014 Jul;22(7):1907-14
pubmed: 24570105
J Palliat Med. 2020 Dec;23(12):1644-1648
pubmed: 32023424
Crit Care Med. 2015 May;43(5):1102-11
pubmed: 25574794
Am J Respir Crit Care Med. 2020 Apr 1;201(7):832-839
pubmed: 31940238
J Palliat Med. 2013 Dec;16(12):1540-9
pubmed: 24225013
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
Med Care. 2009 Jun;47(6):626-33
pubmed: 19433995
J Palliat Care. 2019 Jul 2;:825859719851486
pubmed: 31262230
PLoS One. 2015 Mar 26;10(3):e0121759
pubmed: 25811195
J Palliat Med. 2006 Aug;9(4):855-60
pubmed: 16910799
J Palliat Med. 2020 Dec 18;:
pubmed: 33337265
Palliat Med. 2017 Apr;31(4):378-386
pubmed: 28156192
Am J Hosp Palliat Care. 2018 Jul;35(7):966-971
pubmed: 29169247
J Med Ethics. 2010 Jul;36(7):387-90
pubmed: 20605991
J Palliat Med. 2020 Jan;23(1):107-111
pubmed: 31329015
Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:68-77
pubmed: 31507029
J Palliat Med. 2014 Sep;17(9):1054-63
pubmed: 24984168
J Palliat Med. 2005 Oct;8(5):1033-9
pubmed: 16238516
J Natl Cancer Inst. 2015 Jan 20;107(3):
pubmed: 25609233
CMAJ Open. 2019 Apr 26;7(2):E306-E315
pubmed: 31028054
Curr Opin Crit Care. 2014 Dec;20(6):673-80
pubmed: 25233330
Health Rep. 2020 Oct 21;31(10):3-13
pubmed: 33084290
Cochrane Database Syst Rev. 2013 Jun 06;(6):CD007760
pubmed: 23744578
JAMA. 2016 Jan 19;315(3):272-83
pubmed: 26784775
MDM Policy Pract. 2019 Sep 10;4(2):2381468319866451
pubmed: 31535032
CMAJ. 2012 Aug 7;184(11):1237-45
pubmed: 22733671

Auteurs

Sarina R Isenberg (SR)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada. sisenberg@bruyere.org.
Department of Family and Community Medicine, University of Toronto, Toronto, Canada. sisenberg@bruyere.org.
Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Canada. sisenberg@bruyere.org.
Department of Medicine, University of Ottawa, Ottawa, Canada. sisenberg@bruyere.org.

Christopher Meaney (C)

Department of Family and Community Medicine, University of Toronto, Toronto, Canada.

Peter May (P)

Centre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland.
The Irish Longitudinal study on Ageing (TILDA), Trinity College Dublin, Dublin, Ireland.

Peter Tanuseputro (P)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada.
Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.

Kieran Quinn (K)

Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.
Department of Medicine, University of Toronto, Toronto, Canada.
Department of Medicine, Division of Internal Medicine, Sinai Health, Toronto, Canada.

Danial Qureshi (D)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.

Stephanie Saunders (S)

Temmy Latner Centre for Palliative Care, Sinai Health, Toronto, Canada.

Colleen Webber (C)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.

Hsien Seow (H)

Department of Oncology, McMaster University, Hamilton, Canada.

James Downar (J)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada.
Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, Canada.

Thomas J Smith (TJ)

Department of Medicine, Johns Hopkins Hospital and Health System, Baltimore, USA.
Department of Oncology, Johns Hopkins Hospital and Health System, Baltimore, USA.

Amna Husain (A)

Department of Family and Community Medicine, University of Toronto, Toronto, Canada.
Temmy Latner Centre for Palliative Care, Sinai Health, Toronto, Canada.

Peter G Lawlor (PG)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada.
Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.

Rob Fowler (R)

Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.
Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Tory Trauma Program, Sunnybrook Hospital, Toronto, Canada.

Julie Lachance (J)

End-of-Life Care Unit, Strategic Policy Branch, Health Canada, Ottawa, Canada.

Kimberlyn McGrail (K)

Centre for Health Services and Policy Research, School of Population and Public Health, The University of British Columbia, Vancouver, Canada.

Amy T Hsu (AT)

Bruyère Research Institute, 43 Bruyère St, Office 264J-G, Ottawa, ON, K1N 5C8, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH